Review
Version 1
Preserved in Portico This version is not peer-reviewed
Mutant IDH in Gliomas: Role in Cancer and Treatment Options
Version 1
: Received: 17 April 2023 / Approved: 18 April 2023 / Online: 18 April 2023 (04:12:06 CEST)
Version 2 : Received: 19 April 2023 / Approved: 20 April 2023 / Online: 20 April 2023 (02:28:47 CEST)
Version 2 : Received: 19 April 2023 / Approved: 20 April 2023 / Online: 20 April 2023 (02:28:47 CEST)
A peer-reviewed article of this Preprint also exists.
Solomou, G.; Finch, A.; Asghar, A.; Bardella, C. Mutant IDH in Gliomas: Role in Cancer and Treatment Options. Cancers 2023, 15, 2883. Solomou, G.; Finch, A.; Asghar, A.; Bardella, C. Mutant IDH in Gliomas: Role in Cancer and Treatment Options. Cancers 2023, 15, 2883.
Abstract
Altered metabolism is a common feature of many cancers and in some cases is a consequence of mutation in metabolic genes, such as the ones involved in Krebs cycle. Isocitrate dehydrogenase (IDH) gene is mutated in many gliomas and other cancers. Physiologically IDH converts isocitrate to αketoglutarate (αKG), but when mutated, IDH reduces αKG to D2-hydroxyglutarate (D2-HG). D2-HG accumulates at high levels in IDH mutant cancers, and in the last decade, a massive effort has been done to develop small inhibitors targeting mutant IDH. In this review, we summarize current knowledge about the cellular and molecular consequences of IDH mutations, and the therapeutic approached developed to target IDH mutant tumours, with a focus on gliomas.
Keywords
isocitrate dehydrogenase, cancer metabolism, hydroxyglutarate, gliomas, oncometabolites
Subject
Biology and Life Sciences, Life Sciences
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment